Peritoneal Carcinomatosis clinical trials at University of California Health
3 research studies open to eligible people
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
open to eligible people ages 18 years and up
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
at UC Irvine
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
open to eligible people ages 18 years and up
This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
at UC Irvine
Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
open to eligible people ages 18-75
This is a phase II clinical trial assessing the safety and efficacy of sequential systemic and intraperitoneal (IP) chemotherapy in patients with primary gastric/gastroesophageal junction cancer with cytology positive peritoneal lavage and/or peritoneal carcinomatosis.
at UC Irvine
Our lead scientists for Peritoneal Carcinomatosis research studies include Maheswari Senthil, MD.
Last updated: